نتائج البحث - Antoni Vilaseca
- يعرض 1 - 7 نتائج من 7
-
1
-
2
The Effect of Adverse Surgical Margins on the Risk of Biochemical Recurrence after Robotic-Assisted Radical Prostatectomy حسب Enric Carbonell, Roger Matheu, Maria Muní, Joan Sureda, Mónica García-Sorroche, María José Ribal, Antonio Alcaraz, Antoni Vilaseca
الحاوية / القاعدة Biomedicines (2022-08-01)احصل على النص الكامل
مقال -
3
Cutaneous Adverse Reactions to Apalutamide: Case Series with Clinical and Pathological Correlations حسب Javier Gil-Lianes, Victoria Amat-Samaranch, Priscila Giavedoni, Antoni Vilaseca, Julián Córdoba Sánchez, Francesc Alamon-Reig, Paola Castillo, Adriana P. Garcia, Mariona Pascal, Cristina Carrera
الحاوية / القاعدة Acta Dermato-Venereologica (2024-09-01)احصل على النص الكامل
مقال -
4
Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer حسب Meritxell Pérez, Juan José Lozano, Mercedes Ingelmo-Torres, Montserrat Domenech, Caterina Fernández Ramón, J. Alfred Witjes, Antoine G. van der Heijden, Maria José Requena, Antonio Coy, Ricard Calderon, Begoña Mellado, Antonio Alcaraz, Antoni Vilaseca, Maria J. Ribal
الحاوية / القاعدة Biomedicines (2025-03-01)احصل على النص الكامل
مقال -
5
Apalutamide for prostate cancer: Multicentre and multidisciplinary real‐world study of 227 patients حسب Julián Córdoba Sánchez, Natalia Picola, Alejo Rodriguez‐Vida, Marc Costa, David Marmolejo Castañeda, Meritxell Pérez Márquez, Jesús Muñoz Rodriguez, J. M. Gaya, Alejandra Bravo, Oscar Buisan, Pol Servian, Jose Francisco Suarez, Mireia Musquera Felip, Maria Jose Ribal Caparrós, Antonio Alcaraz Asensio, Antoni Vilaseca
الحاوية / القاعدة Cancer Medicine (2023-12-01)احصل على النص الكامل
مقال -
6
Prostate-specific Antigen at 3 Months as a Predictor of Radiologic Progression-free Survival in Metastatic Hormone-sensitive Prostate Cancer Treated with Apalutamide: Analysis of 6... حسب Mario Hassi Roman, Kinga Mate, Pedro De Pablos-Rodriguez, Álvaro Zamora Horcajada, Ana Guijarro Cascales, Ángeles Sanchís Bonet, Antoni Vilaseca, Darío Vázquez-Martul Pazos, Estefanía Linares Espinós, Jesús Muñoz Rodríguez, José Manuel de la Morena Gallego, José Ramón Alemán, Juan Gómez Rivas, Luigi Formisano, Maria J. Juan Fita, Marc Costa Planells, Mario Domínguez Esteban, Meritxell Pérez Márquez, Miguel García Sanz, Nagore García Expósito, Natalia Picola, Pol Servian Vives, Raquel Sopeña Sutil, Miguel A. Climent Durán, Miguel Ramírez Backhaus
الحاوية / القاعدة European Urology Open Science (2024-12-01)احصل على النص الكامل
مقال -
7
AGREE II Quality Assessment of National and International Clinical Practice Guidelines on Prostate Cancer Management by the OPTIMA Consortium حسب Vasileios Sakalis, Yagnaseni Bhattacharya, Katharina Beyer, Charlotte Murray, Emma Jane Smith, Peter-Paul M. Willemse, Giorgio Gandaglia, Romain Boissier, Angelika Borkowetz, Saeed Dabestani, Renee C.A. Leenen, Antoni Vilaseca, Gianluca Maresca, Jeremy Teoh, Juan Gómez Rivas, Pawel Rajwa, Michael Lardas, Nikolas Grivas, Thomas Van den Broeck, Benjamin Pradere, Natasha Schouten, Zafer Tandogdu, Susan Evans-Axelsson, Steven Maclennan, Marlene Thomas, Alberto Briganti, Anders Bjartell, Phil Cornford, Hagen Kruger, James N’Dow, Monique J. Roobol, Muhammad Imran Omar
الحاوية / القاعدة European Urology Open Science (2024-12-01)احصل على النص الكامل
مقال
